Details for New Drug Application (NDA): 019353
✉ Email this page to a colleague
The generic ingredient in ALFENTA is alfentanil hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.
Summary for 019353
Tradename: | ALFENTA |
Applicant: | Rising |
Ingredient: | alfentanil hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 019353
Mechanism of Action | Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 019353
Suppliers and Packaging for NDA: 019353
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353 | NDA | Akorn | 17478-067 | 17478-067-02 | 10 AMPULE in 1 CARTON (17478-067-02) / 2 mL in 1 AMPULE |
ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353 | NDA | Akorn | 17478-067 | 17478-067-05 | 10 AMPULE in 1 CARTON (17478-067-05) / 5 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.5MG BASE/ML | ||||
Approval Date: | Dec 29, 1986 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 019353
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rising | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription